OCULAR COMPLICATIONS IN CUTANEOUS LUPUS ERYTHEMATOSUS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i8.1824Keywords:
Eye, Cutaneous lupus erythematosus, Ocular complicationsAbstract
Introduction: Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by disruption of tear film homeostasis, instability of the tear film, and inflammation of the ocular surface. Although the precise mechanism of action is still inadequately understood, numerous studies have demonstrated that IPL has the potential to alleviate both the signs and symptoms of dry eye.
The aim: This article showed ocular complications in cutaneous lupus erythematosus.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 115 articles, whereas the results of our search on SagePub brought up 97 articles. The results of the search conducted for the last year of 2013 yielded a total 32 articles for PubMed and 26 articles for SagePub. In the end, we compiled a total of 27 papers, 14 of which came from PubMed and 13 of which came from SagePub. We included nine research that met the criteria.
Conclusion: SLE ocular symptoms can indicate active SLE. In daily ophthalmology, SLE should be considered a differential diagnosis, especially for symptoms. Systemic treatment is based on ophthalmology. SLE management requires division and medical field collaboration. Systemic treatment includes antimalarials, corticosteroids, immunomodulators, and biologics.
References
Conigliaro P, Cesareo M, Chimenti MS, Triggianese P, Canofari C, Barbato C, et al. Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view. Autoimmun Rev [Internet] 2019;18(3):247–54. Available from: https://www.sciencedirect.com/science/article/pii/S1568997219300047
Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391–404.
Grönhagen CM, Nyberg F. Cutaneous lupus erythematosus: An update. Indian Dermatol Online J. 2014 Jan;5(1):7– 13.
Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10(6):365–81.
Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135– 49.
Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050–70.
Papagiannuli E, Rhodes B, Wallace GR, Gordon C, Murray PI, Denniston AK. Systemic lupus erythematosus: an update for ophthalmologists. Surv Ophthalmol. 2016;61(1):65–82.
Hejazi EZ, Werth VP. Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment. Am J Clin Dermatol. 2016;17:135–46.
Arrico L, Abbouda A, Abicca I, Malagola R. Ocular complications in cutaneous lupus erythematosus: a systematic review with a meta-analysis of reported cases. J Ophthalmol. 2015;2015.
Santoro FA, Huang J. Ocular involvement in cutaneous connective tissue disease. Clin Dermatol. 2016;34(2):138– 45.
Vijayasankar P, Karthikeyan K. Discoid lupus erythematosus of eyelids–Diagnostic and therapeutic challenges. Saudi J Ophthalmol. 2021;35(4):353.
Theisen E, Tiao J, Fedeles F. Periorbital discoid lupus erythematosus: A retrospective study. JAAD Case Reports. 2022;25:78–82.
Chan AJ, Rai AS, Lake S. Orbital myositis in systemic lupus erythematosus: a case report and literature review. Eur J Rheumatol. 2020;7(3):135.
Lo Y, Jee S, Cheng Y. Periorbital heliotrope edema as an uncommon manifestation of juvenile‐onset systemic lupus erythematosus. Kaohsiung J Med Sci. 2020;36(9):759–60.
Rico M, Díaz‐López JB, Peña J, Oliva‐Nacarino P. Latent orbital pseudotumor secondary to systemic lupus erythematosus. Clin Case Reports. 2016;4(11):1065.
Cakici O, Karadag R, Bayramlar H, Ozkanli S, Uzuncakmak TK, Karadag AS. Periorbital discoid lupus: a rare localization in a patient with systemic lupus erythematosus. An Bras Dermatol. 2016;91:122–4.
Arrico L, Abbouda A, Bianchi S, Malagola R. Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep. 2014 Nov;8:375.
Kono S, Takashima H, Suzuki D, Terada T, Konishi T, Miyajima H. Orbital myositis associated with discoid lupus erythematosus. Vol. 23, Lupus. England; 2014. p. 220–2.
Kopsachilis N, Tsaousis KT, Tourtas T, Tsinopoulos IT. Severe chronic blepharitis and scarring ectropion associated with discoid lupus erythematosus. Clin Exp Optom. 2013 Jan;96(1):124–5.
Rachwani-Anil R, Zamorano-Martín F, Rocha-De-Lossada C, García-Lorente M, Pérez-Casaseca C, HernandoAyala C, et al. Orbital inflammatory disease. Arch la Soc Española Oftalmol (English Ed. 2022;97(2):89–99.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
